Navigation Links
Results From an Expanded Cohort Phase 1 Study Published in the New England Journal of Medicine Demonstrate a Majority of Patients With ALK-Positive Advanced Non-Small Cell Lung Cancer Responded to Crizotinib (PF-02341066)
Date:10/27/2010

31, 2010.

(4) Bang Y et al. Clinical Activity of the Oral ALK Inhibitor, PF-02341066, in ALK Positive Patients with Non-Small Cell Lung Cancer (NSCLC). Accepted Plenary Presentation at the American Society of Clinical Oncology 2010 Annual Meeting, June 4-8, 2010.

(5) Chiarle R, Voena C, Ambrogio C et al. The anaplastic lymphoma kinase in the pathogenesis of cancer. Nat Rev Cancer. 2008;8(1): 11-23.

(6) ClinicalTrials.gov. An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care in Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene.  2010. Available at: http://clinicaltrials.gov/ct2/show/NCT00932893. Accessed August 23, 2010.

(7) ClinicalTrials.gov. An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene. Available at: http://www.clinicaltrials.gov/ct2/show/NCT00932451. Accessed August 23, 2010.

(8) Bang Y et al. Clinical Activity of the Oral ALK Inhibitor, Crizotinib (PF-02341066), in Patients with ALK-positive Non-Small Cell Lung Cancer. Accepted Plenary Presentation at the American Society of Clinical Oncology 2010 Annual Meeting, June 4-8, 2010. Chicago, IL.

(9) American Cancer Society.  Global Cancer Facts & Figures 2007.  Atlanta, Ga: American Cancer Society: 2007.

(10) Reade CA, Ganti AK. EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab. Biologics. 2009; 3: 215–224.

(11) American Cancer Society. Detailed Guide: Lung Cancer (Non-Small Cell). Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/00
'/>"/>

SOURCE Pfizer Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
5. Tapestry Reports Second Quarter 2007 Results
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  Growth of the U.S. nonprescription market is ... prescription users to the OTC market. Due to an ... Rx-to-OTC switch activity over the next five years with ... new brands entering the market into existing categories. ... years (even those with low to moderate likelihood), the ...
(Date:7/30/2015)... OSAKA, Japan , July 30, 2015 /PRNewswire/ ... completion of the study to fulfill the post-marketing ... from the Pan European Multi-Database Bladder Cancer ... multi-database retrospective matched cohort study, conducted in four ... (pioglitazone HCI) with up to 10 years of ...
(Date:7/30/2015)... , July 30, 2015   Sentrian , ... all preventable hospitalization, recently received confirmation from the ... Patient Intelligence (RPI) solution meets the definition of ... to exercise "Enforcement Discretion." The ... to further FDA regulatory requirements at this time" ...
Breaking Medicine Technology:Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 2Rx-to-OTC Switches -- Game Changers for the U.S. OTC Drugs Market through 2019, Sees Kline 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
(Date:7/31/2015)... ... , ... BioViva USA, Inc. (“BioViva”), a to-clinic gene therapy company based in ... announces it has begun a fundraiser through Maximum Life Foundation (“MaxLife”) to use a ... MaxLife will grant 100% of the money raised to BioViva to help bring pioneering ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... ... 20-21, 2015 – Washington, DC, http://www.fdanews.com/importexportprogram , Having FDA-regulated products held ... have to. , Instead of risking containment — or even destruction — of ...
(Date:7/31/2015)... ... 2015 , ... Florida Hospital Tampa has started treating select ... targeted delivery of fluids to selected sites in the peripheral vascular system. Patients ... the device that provides direct, local delivery of chemotherapy to the pancreas. This ...
(Date:7/31/2015)... ... July 31, 2015 , ... Ticket Down is a reputable source of ... Women's National Soccer Team will face the Australia Women's National Team in two separate ... Ford Field in Detroit and the second match will occur in Birmingham, Alabama at ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... Indosoft, Inc., ... builder in Q-Suite 5.9. Q-Suite is their flagship contact center ACD system for ... the agent script display logic shows the script components to the agent only when ...
Breaking Medicine News(10 mins):Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 2Health News:BioViva USA, Inc.’s Alzheimer’s Disease Gene Therapy Human Trial 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 2Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 3Health News:FDAnews Announces — Successful Import/Export Programs: Former FDA Expert Shows the Way, Oct. 20-21, 2015 4Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 2Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 3Health News:Florida Hospital Tampa Expands Treatment Options for Patients with Pancreatic Cancer Using New Catheter Technology 4Health News:Cheap USA vs. Australia Tickets at Legion Field in Birmingham, AL: Ticket Down Slashes Ticket Prices for Australia vs. USWNT at Legion Field 2Health News:Q-Suite 5.9 Adds Validation Tools to Call Center Software Agent Screen 2
... an opportunity for,growth beyond San Antonio, KGS Bikes, ... is expanding into the Dallas area. They will ... month in the,new market in order to meet ... The fitting process involves a dynamic session ...
... with Retirement Accounts Would Borrow From Funds to Cover ... ... worries stemming,from current economic conditions, it appears that U.S. employees are just,as ... to an unexpected illness or injury, according to a recent survey,from Berkshire ...
... many X-rays, CT scans and nuclear medicine tests led ... -- Long-term buildup of radiation resulting from repeated emergency ... at an increased risk for developing cancer, new research ... currently in widespread use in hospitals across the United ...
... CHAPEL HILL The University of North Carolina at ... of Health (NIH) grant that will help speed up ... North Carolina. , UNC is among 14 academic ... of the NIHs Clinical and Translational Science Award (CTSA) ...
... at major worldwide congresses prior to ECLU, the ... from a comprehensive review of the latest cutting-edge ... the field. , The conference includes extensive opportunities ... experience exchange. , Highlights sessions: a ...
... Gifted Song Stylist, International Award Winning ... Breast Cancer, DALLAS, May 29 Susan G. ... three of today,s prominent African-American,leaders -- each with different ... that is empowering people around the globe to help,end ...
Cached Medicine News:Health News:KGS Bikes Offers Fittings to Dallas' Discriminating Cyclists 2Health News:KGS Bikes Offers Fittings to Dallas' Discriminating Cyclists 3Health News:Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability 2Health News:Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability 3Health News:Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability 4Health News:Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability 5Health News:Guardian Survey: Fear of Losing Income Due to the Economy Equals Fear of Losing Income Due to Disability 6Health News:Certain Tests in ERs Raise Cancer Risk for Some 2Health News:Certain Tests in ERs Raise Cancer Risk for Some 3Health News:Certain Tests in ERs Raise Cancer Risk for Some 4Health News:New federally-funded health initiative to speed benefits of science to North Carolinians 2Health News:ESMO Conference Lugano 2Health News:Susan G. Komen for the Cure(R)'s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors 2Health News:Susan G. Komen for the Cure(R)'s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors 3Health News:Susan G. Komen for the Cure(R)'s Circle of Promise Welcomes Gabrielle Union, Lalah Hathaway, Synthia SAINT JAMES as National Ambassadors 4
10-mm (0.4-in) diameter cups have multi-color lead wires and 2-mm (0.08-in) holes for easy paste/collodion application. Available in a variety of lengths to suit many different needs....
... Made with elastic fabric, these head cap ... need to begin testing. Each Electro-Cap System ... the International 10-20 System. When you place ... are using with your head cap system ...
... Made with elastic fabric, these head ... you need to begin testing. Each Electro-Cap ... to the International 10-20 System. When you ... you are using with your head cap ...
... head cap systems are packaged to provide ... Electro-Cap System features pure tin electrodes positioned ... you place your order, please specify which ... cap system and whether you want regular ...
Medicine Products: